Cargando…
Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells
Background: Treatment of large bone defects due to trauma, tumor resection, or congenital abnormalities is challenging. Bone tissue engineering using mesenchymal stem cells (MSCs) represents a promising treatment option. However, the quantity and quality of engineered bone tissue are not sufficient...
Autores principales: | Groeneveldt, Lisanne C., Knuth, Callie, Witte-Bouma, Janneke, O’Brien, Fergal J., Wolvius, Eppo B., Farrell, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151337/ https://www.ncbi.nlm.nih.gov/pubmed/25229057 http://dx.doi.org/10.3389/fbioe.2014.00029 |
Ejemplares similares
-
Pediatric Mesenchymal Stem Cells Exhibit Immunomodulatory Properties Toward Allogeneic T and B Cells Under Inflammatory Conditions
por: Palomares Cabeza, Virginia, et al.
Publicado: (2019) -
Chondrogenic differentiation of mesenchymal stem cells through cartilage matrix-inspired surface coatings
por: Zhao, Mingyan, et al.
Publicado: (2022) -
Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model
por: Fahy, Niamh, et al.
Publicado: (2021) -
Hybrid Bioprinting of Chondrogenically Induced Human Mesenchymal Stem Cell Spheroids
por: De Moor, Lise, et al.
Publicado: (2020) -
Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment
por: Voskamp, Chantal, et al.
Publicado: (2020)